Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Vivian Boshra"'
Autor:
Elkatary, Rania Gamal, El Beltagy, Hussein Mahmoud, Abdo, Vivian Boshra, El Fatah, Dina Sabry Abd, El-Karef, Amr, Ashour, Rehab Hamdy
Publikováno v:
In Environmental Toxicology and Pharmacology October 2023 103
Autor:
Elshenawy, Dina Salem Abdelaziz, Ramadan, Nehal Mohammed, Abdo, Vivian Boshra, Ashour, Rehab Hamdy
Publikováno v:
In Biomedicine & Pharmacotherapy September 2022 153
Autor:
Elshenawy, Dina Salem Abdelaziz, Ramadan, Nehal Mohammed, Abdo, Vivian Boshra, Ashour, Rehab Hamdy
Publikováno v:
In Biomedicine & Pharmacotherapy December 2022 156
Autor:
Dina Salem Abdelaziz Elshenawy, Nehal Mohammed Ramadan, Vivian Boshra Abdo, Rehab Hamdy Ashour
Publikováno v:
Biomedicine & Pharmacotherapy. 156:113867
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e253ad094b648ec4df9467b679115e07
https://doi.org/10.1016/j.biopha.2022.113867
https://doi.org/10.1016/j.biopha.2022.113867
Autor:
Dina Salem Abdelaziz, Elshenawy, Nehal Mohammed, Ramadan, Vivian Boshra, Abdo, Rehab Hamdy, Ashour
Publikováno v:
Biomedicine & Pharmacotherapy. 153:113382
Diabetic cardiomyopathy (DCM) is linked to disturbance in cardiac glucose handling and increased cardiac glycogen storage. This study tested the potential role of sacubitril/valsartan on the progression of DCM in high fat diet (HFD)/streptozotocin (S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e98e7ce0564a491a6890ca2fed2c2515
https://doi.org/10.1016/j.biopha.2022.113382
https://doi.org/10.1016/j.biopha.2022.113382
Publikováno v:
Current Drug Therapy. 12:64-72
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::119050f9c5319f766a35c8f9e2bd9f67
https://doi.org/10.2174/1574885512666170106105548
https://doi.org/10.2174/1574885512666170106105548
Autor:
Vivian Boshra, Wagdi Elkashef
Publikováno v:
British Journal of Medicine and Medical Research. 20:1-13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6183395858d90534f2d2c87b51e8c482
https://doi.org/10.9734/bjmmr/2017/32349
https://doi.org/10.9734/bjmmr/2017/32349
Autor:
Amany Shalaby, Vivian Boshra
Publikováno v:
British Journal of Medicine and Medical Research. 6:1166-1176
Doxorubicin (DOX) has been used in variety of human malignancies for decades. Despite its efficacy in cancer, clinical usage is limited because of its cardiotoxicity, which has been associated with oxidative stress. The possible protective mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88e6997e813ad6f97d0d1fe48a46e25d
https://doi.org/10.9734/bjmmr/2015/10764
https://doi.org/10.9734/bjmmr/2015/10764
Autor:
Vivian Boshra, Gehan Hamid El Wakeel
Publikováno v:
Current Drug Therapy. 8:164-170
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3dc421dd9334165e006e010d755ab998
https://doi.org/10.2174/15748855113086660010
https://doi.org/10.2174/15748855113086660010
Autor:
Amr M. Abbas, Vivian Boshra
Publikováno v:
Journal of basic and clinical physiology and pharmacology. 28(4)
Background:Renovascular hypertension (RVH) is a result of renal artery stenosis, which is commonly due to astherosclerosis. In this study, we aimed to clarify the central and peripheral effects of ghrelin on the renin-angiotensin system (RAS) in a ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8e66f1a650dcfd50966784762929185
https://pubmed.ncbi.nlm.nih.gov/28315847
https://pubmed.ncbi.nlm.nih.gov/28315847